APA Alıntı

Gäbler, K., Behrmann, I., & Haan, C. (2013). JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms. Landes Bioscience.

Chicago Stili Alıntı

Gäbler, Karoline, Iris Behrmann, ve Claude Haan. JAK2 Mutants (e.g., JAK2V617F) and Their Importance As Drug Targets in Myeloproliferative Neoplasms. Landes Bioscience, 2013.

MLA Alıntı

Gäbler, Karoline, Iris Behrmann, ve Claude Haan. JAK2 Mutants (e.g., JAK2V617F) and Their Importance As Drug Targets in Myeloproliferative Neoplasms. Landes Bioscience, 2013.